Autonomous drug discovery via generative molecular design is critically bottlenecked by the production of chemically intractable structures. Multi-trillion-scale make-on-demand libraries guarantee synthetic feasibility, but conventional virtual screening cannot efficiently navigate these vast spaces or address multi-pa...
Seonghwan Seo, Yulseung Sung, Sang-Yeon Hwang et al.· bioRxiv· 0 citations
The Atlas model family is presented, an open and trainable system spanning protein language modeling, monomer folding, and protein-complex prediction, and the training code and data, stage checkpoints, and model weights under the MIT License are released to provide a foundation for advancing PLM-based protein structure...
Seonghwan Seo, Hyeongwoo Kim, Seokhyun Moon et al.· bioRxiv· 0 citations
Boltz2ESI is introduced, an end-to-end framework that predicts enzyme–substrate interactions by leveraging structural knowledge learned by a biomolecular foundation model and consistently outperforms state-of-the-art sequence-based and rigid-docking approaches.
Xi-Wei Cheng, Seonghwan Seo, C. Huh et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.